Volume 23, Number 9—September 2017
Conveyance Contact Investigation for Imported Middle East Respiratory Syndrome Cases, United States, May 2014
||Signs and symptoms
|Index case||Laboratory-confirmed MERS-CoV infection in a person who traveled by commercial aircraft or bus while symptomatic. A traveler who tested positive for MERS-CoV was considered to have been contagious if symptomatic while on the conveyance.||Fever (>38°C [>100.4°F]) or feverishness;† or symptoms of acute respiratory illness (i.e., cough, shortness of breath, rhinorrhea, sore throat); or myalgia, malaise; or gastrointestinal symptoms (i.e., nausea, diarrhea, or vomiting).|
|Conveyance contact||A person who traveled on the same conveyance as the index case-patient and who had:|
|Category 1||Compatible symptoms within 2–14 d after the flight or bus ride.||Fever (>38°C [100.4°F]) or feverishness; or symptoms of acute respiratory illness (i.e., cough, shortness of breath, rhinorrhea, sore throat); or myalgia, malaise; or gastrointestinal symptoms (i.e., nausea, diarrhea, or vomiting).|
|Category 2||Unrelated symptoms.||An illness before the flight or an illness with onset either <2 d or >14 d after the flight; or symptoms attributable to a chronic illness; or symptoms that were musculoskeletal, neurologic, or dermatologic in origin.|
|Patient under investigation‡
||Clinical features (severe or milder illness), including fever and respiratory symptoms, and epidemiologic risk factors, including travel, healthcare setting, and contact history.
|Incubation period for MERS-CoV infection||2–14 d after exposure.|
*CDC, Centers for Disease Control and Prevention; MERS, Middle East respiratory syndrome; MERS-CoV, MERS coronavirus.
†A subjective sense of fever.
- Page created: August 17, 2017
- Page last updated: August 17, 2017
- Page last reviewed: August 17, 2017
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)